Stable Istotope Labelled Brodalumab Biosimilar – Anti-IL17RA/CD217 mAb – Research Grade

Reference: PX-TA1268-SIL-1MG
Product nameStable Istotope Labelled Brodalumab Biosimilar - Anti-IL17RA/CD217 mAb - Research Grade
SourceCAS 1174395-19-7
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsAMG827,KHK4827
ReferencePX-TA1268-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-IL17RA/CD217[Homo sapiens] (Brodalumab) Monoclonal Antibody

Brodalumab has been investigated for the treatment of Asthma, Psoriasis, Crohn’s Disease, Psoriatic Arthritis, and Rheumatoid Arthritis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Brodalumab Biosimilar – Anti-IL17RA/CD217 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below